Don't Miss

Fidson calls for support from NAFDAC against drug counterfeiting

By on January 5, 2013

Fidelis Ayebae MD/CEO Fidson Healthcare Plc

Fidson Healthcare Plc, a manufacturing giant yesterday called on stakeholders in the pharmaceutical industry to lend a helping hand to the National Agency for Food, Drugs Administration, and Control (NAFDAC) on the fight against fake drugs and their agents.

The fight against drug counterfeiting has affected the health and image of the country for so many years now, irrespective of the tireless efforts put in place by NAFDAC.

Speaking against the menace, the Operations Director of Fidson Healthcare Plc, Mr Abiola Adebayo said, the effects of drug counterfeiting on the country are devastating, affecting the industry and economy of the country.

Adebayo maintained that “It is imperative to see the on-going campaign beyond just one of NAFDAC, activities. The problem of fake drugs is neither a NAFDAC problem nor that of the pharmaceutical industry. It is a serious national issue because it has to do with human lives. Hence everybody, including pharmaceutical firms must join hands with NAFDAC in this fight.”

NAFDAC has moved against fake drugs syndicates, fostering public enlightenment campaigns and collaborating with other security agencies in the country.

Adebayo, however, called on stakeholders in the pharmaceutical industry to support NAFDAC in the fight against those whose concern is to soil the name of the country.